No Data
PEPG PepGen
Watchlist- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About PepGen Company
PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Boston, MA.
News
Analysts Are Bullish on These Healthcare Stocks: PepGen Inc. (PEPG), Cidara Therapeutics (CDTX)
PepGen Inc. Announces Clearance Of CTA By Health Canada To Begin FREEDOM-DM1 Phase 1 Study Of PGN-EDODM1 In Patients With Myotonic Dystrophy Type 1
PepGen Inc. Announces Clearance Of CTA By Health Canada To Begin FREEDOM-DM1 Phase 1 Study Of PGN-EDODM1 In Patients With Myotonic Dystrophy Type 1
PepGen Inc. Announces Clearance of CTA by Health Canada to Begin the FREEDOM-DM1 Phase 1 Study of PGN-EDODM1 in Patients With Myotonic Dystrophy Type 1
The U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation to PGN-EDODM1 for the treatment of Myotonic Dystrophy Type 1 (DM1).
chris from queens : wow..this woulda been nice...gonna look at the chart now let's see what tomorrow can bring. Thanks I'm up late or early whatever you wanna call it glad I seen this ASAP
chris from queens : right off the bat nice market cap with low ass float

chris from queens : phase 2 for MS...wow
and their quarterly report last week fundys are looking proper. good looks Alvin!
Alvinnnnnnn89OP chris from queens: i actually looking for pt 20-30 long term
Alvinnnnnnn89OP chris from queens: Looking for dips entry now
View more comments...